Published in PLoS Negl Trop Dis on September 04, 2014
Economic Impact of Dengue: Multicenter Study across Four Brazilian Regions. PLoS Negl Trop Dis (2015) 0.92
Costs of Dengue Control Activities and Hospitalizations in the Public Health Sector during an Epidemic Year in Urban Sri Lanka. PLoS Negl Trop Dis (2016) 0.84
From best evidence to best practice: effective implementation of change in patients' care. Lancet (2003) 27.61
Dengue: a continuing global threat. Nat Rev Microbiol (2010) 9.96
The Brazilian health system: history, advances, and challenges. Lancet (2011) 7.11
Enzyme-linked immunosorbent assay specific to Dengue virus type 1 nonstructural protein NS1 reveals circulation of the antigen in the blood during the acute phase of disease in patients experiencing primary or secondary infections. J Clin Microbiol (2002) 4.63
How good is the quality of health care in the United States? Milbank Q (1998) 4.61
Cost-of-illness methodology: a guide to current practices and procedures. Milbank Mem Fund Q Health Soc (1982) 3.97
Economic impact of dengue illness in the Americas. Am J Trop Med Hyg (2011) 3.52
Cost of dengue cases in eight countries in the Americas and Asia: a prospective study. Am J Trop Med Hyg (2009) 3.42
Molecular evolution of dengue viruses: contributions of phylogenetics to understanding the history and epidemiology of the preeminent arboviral disease. Infect Genet Evol (2009) 3.19
Multicentre prospective study on dengue classification in four South-east Asian and three Latin American countries. Trop Med Int Health (2011) 2.60
The molecular epidemiology of dengue virus serotype 4 in Bangkok, Thailand. Virology (2004) 2.42
Economic cost of dengue in Puerto Rico. Am J Trop Med Hyg (2012) 2.38
Evaluation of the traditional and revised WHO classifications of Dengue disease severity. PLoS Negl Trop Dis (2011) 2.26
Usefulness and applicability of the revised dengue case classification by disease: multi-centre study in 18 countries. BMC Infect Dis (2011) 2.03
Hospital mortality: when failure is not a good measure of success. CMAJ (2008) 1.98
Economic note: cost of illness studies. BMJ (2000) 1.75
Platelet transfusion practice during dengue fever epidemic. Indian J Pathol Microbiol (2000) 1.74
Evaluating the sensitivity of a commercial dengue NS1 antigen-capture ELISA for early diagnosis of acute dengue virus infection. Singapore Med J (2007) 1.71
Lack of efficacy of prophylactic platelet transfusion for severe thrombocytopenia in adults with acute uncomplicated dengue infection. Clin Infect Dis (2009) 1.53
The health and economic impact of dengue in Latin America. Cad Saude Publica (2007) 1.49
Highly sensitive detection of dengue virus nucleic acid in samples from clinically ill patients. J Clin Microbiol (2009) 1.43
Prospective observational study of low thresholds for platelet transfusion in adult dengue patients. Transfusion (2009) 1.13
[Socio-demographic profile and utilization patterns of the public healthcare system (SUS), 2003-2008]. Cien Saude Colet (2011) 1.05
Evaluation of the traditional and revised World Health Organization classifications of dengue cases in Brazil. Clinics (Sao Paulo) (2013) 0.98
Prophylactic platelets in dengue: survey responses highlight lack of an evidence base. PLoS Negl Trop Dis (2012) 0.89
Unfurling the rationale use of platelet transfusion in dengue Fever. Indian J Hematol Blood Transfus (2011) 0.88
Evaluation of the WHO classification of dengue disease severity during an epidemic in 2011 in the state of Ceará, Brazil. Mem Inst Oswaldo Cruz (2014) 0.87
Perioperative prophylactic antithrombotic strategies in vascular surgery: current practice in the Netherlands. J Cardiovasc Surg (Torino) (2013) 0.79